Hizentra and Skin cancer - a phase IV clinical study of FDA data

Summary:

Skin cancer is reported as a side effect among people who take Hizentra (human immunoglobulin g), especially for people who are female, 60+ old, also take Epipen, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Skin cancer when taking Hizentra. It is created by eHealthMe based on reports of 23,644 people who have side effects when taking Hizentra from the FDA, and is updated regularly.

What is Hizentra?

Hizentra has active ingredients of human immunoglobulin g. eHealthMe is studying from 23,666 Hizentra users. Check the latest studies of Hizentra.

What is Skin cancer?

Skin cancer is found to be associated with 919 drugs and 802 conditions by eHealthMe. Check the latest studies of Skin cancer.

On Jul, 11, 2026

23,644 people reported to have side effects when taking Hizentra.
Among them, 19 people (0.08%) have Skin cancer.

Among these 19 people:

What is the gender of people who have Skin cancer when taking Hizentra? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Skin cancer when taking Hizentra? *

What are other drugs people take besides Hizentra? *

What are other side effects people have besides Skin cancer? *

Dyspnea (difficult or laboured breathing): 4 people, 21.05%
Dizziness: 4 people, 21.05%
Abdominal Pain: 3 people, 15.79%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 15.79%
Otitis (ear infection): 3 people, 15.79%
Perfume Sensitivity: 3 people, 15.79%
Weight Increased: 3 people, 15.79%
Postoperative Wound Infection: 3 people, 15.79%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 15.79%
Localised Infection (infection at the single location): 3 people, 15.79%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 11 people, 57.89%
Urinary Tract Infection: 1 person, 5.26%
Secondary Immunodeficiency (lack of immunity due to some disease): 1 person, 5.26%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.26%
Constipation: 1 person, 5.26%
Dermal Cyst: 1 person, 5.26%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 1 person, 5.26%
Immune System Disorder: 1 person, 5.26%
Immunodeficiency: 1 person, 5.26%
Inflammation: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Hizentra and have Skin cancer?

- Check whether Skin cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hizentra:

Hizentra (23,666 reports)

Skin cancer treatments and more:

Skin cancer (26,073 reports)

Browse all side effects of Hizentra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin cancer:

Skin cancer (919 drugs)

Browse all the conditions that are associated with Skin cancer:

Skin cancer (802 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on human immunoglobulin g (the active ingredients of Hizentra) and Hizentra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.